[Neuropsychiatric complications associated with digestive system agents].
Nagai
Masahiro
M
Ehime University School of Medicine.
Nomoto
Masahiro
M
D000998:Antiviral Agents / Q000009:adverse effects; D002800:Cholinesterase Inhibitors / Q000009:adverse effects; D018492:Dopamine Antagonists / Q000009:adverse effects; D004347:Drug Interactions; D005765:Gastrointestinal Agents / Q000009:adverse effects*; D006635:Histamine H2 Antagonists / Q000009:adverse effects; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects; D016899:Interferon-beta / Q000009:adverse effects; D001523:Mental Disorders / Q000139:chemically induced*; D017366:Serotonin Receptor Agonists / Q000009:adverse effects
D000998:Antiviral Agents; D002800:Cholinesterase Inhibitors; D018492:Dopamine Antagonists; D005765:Gastrointestinal Agents; D006635:Histamine H2 Antagonists; D016898:Interferon-alpha; D017366:Serotonin Receptor Agonists; D016899:Interferon-beta